Healx
Healx is a Cambridge-based biotech using generative AI to accelerate drug discovery and develop treatments for rare diseases that currently lack approved therapies.
About
Healx is a generative AI-enabled, clinical-stage rare disease biotech pioneering the next generation of drug discovery to bring novel, effective treatments to rare disease patients around the world. Of the 10,000 known rare diseases affecting 400 million people globally, only 5% have an approved treatment.
By combining generative AI technology with deep drug discovery and development expertise, Healx accelerates the pace, increases the scale, and improves the success rate of rare disease treatment development—delivering meaningful impact for patients worldwide. The company exists because every rare disease patient deserves a treatment.
Healx was founded in Cambridge, UK, by Tim Guilliams, Ph.D., a biochemical engineer and tech entrepreneur, and David Brown, Ph.D., co-inventor of Viagra and former global head of drug discovery at Roche.
